Literature DB >> 2429634

Focal and segmental glomerulosclerosis. Immunohistologic study of 20 renal biopsy specimens.

G N Gephardt, R R Tubbs, K L Popowniak, J T McMahon.   

Abstract

To evaluate the deposition of immunoglobulins and complement and their relationship to sclerotic and nonsclerotic glomerular segments, immunoperoxidase without periodic acid-Schiff counterstain (IMP) and with periodic acid-Schiff counterstain (IMPAS) for IgG, IgA, IgM, and C3 was performed on cryostat-frozen sections using the direct method, along with routine light microscopy and electron microscopy, in a series of 20 renal biopsy specimens from 20 patients with the final diagnosis of focal and segmental glomerulosclerosis. Neither diffuse mesangial nor diffuse glomerular basement membrane deposits were detected by IMP, IMPAS, or electron microscopy. In 18 biopsy specimens, IMPAS demonstrated focal and segmental granular to globular deposits of IgM and/or C3 in sclerotic glomerular segments. In eight biopsy specimens, small granular deposits of IgM and/or C3 deposits were identified in optically normal glomeruli, suggesting that these deposits may precede segmental sclerosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429634

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  8 in total

1.  Retinal drusen in glomerulonephritis with or without immune deposits suggest systemic complement activation in disease pathogenesis.

Authors:  P Harraka; H Mack; D Colville; D Barit; D Langsford; T Pianta; F Ierino; Judy Savige
Journal:  Sci Rep       Date:  2022-05-17       Impact factor: 4.996

2.  Clinical Significance of IgM and C3 Glomerular Deposition in Primary Focal Segmental Glomerulosclerosis.

Authors:  Yi-Miao Zhang; Qiu-Hua Gu; Jing Huang; Zhen Qu; Xin Wang; Li-Qiang Meng; Fang Wang; Gang Liu; Zhao Cui; Ming-Hui Zhao
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 8.237

3.  IgM contributes to glomerular injury in FSGS.

Authors:  Derek Strassheim; Brandon Renner; Sarah Panzer; Richard Fuquay; Liudmila Kulik; Danica Ljubanović; V Michael Holers; Joshua M Thurman
Journal:  J Am Soc Nephrol       Date:  2013-02-07       Impact factor: 10.121

4.  IgM exacerbates glomerular disease progression in complement-induced glomerulopathy.

Authors:  Sarah E Panzer; Jennifer Laskowski; Brandon Renner; Liudmila Kulik; Danica Ljubanovic; Kendra M Huber; Weixiong Zhong; Matthew C Pickering; V Michael Holers; Joshua M Thurman
Journal:  Kidney Int       Date:  2015-05-06       Impact factor: 10.612

5.  The impact of IgM deposits on the outcome of Nephrotic syndrome in children.

Authors:  Sandra Juozapaite; Rimante Cerkauskiene; Arvydas Laurinavicius; Augustina Jankauskiene
Journal:  BMC Nephrol       Date:  2017-08-03       Impact factor: 2.388

6.  Complement Activation in Patients with Focal Segmental Glomerulosclerosis.

Authors:  Joshua M Thurman; Maria Wong; Brandon Renner; Ashley Frazer-Abel; Patricia C Giclas; Melanie S Joy; Diana Jalal; Milena K Radeva; Jennifer Gassman; Debbie S Gipson; Frederick Kaskel; Aaron Friedman; Howard Trachtman
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

7.  IgM as a novel predictor of disease progression in secondary focal segmental glomerulosclerosis.

Authors:  Arijana Pačić; Petar Šenjug; Jasna Bacalja; Miroslav Tišljar; Ivica Horvatić; Stela Bulimbašić; Mladen Knotek; Krešimir Galešić; Danica Galešić Ljubanović
Journal:  Croat Med J       Date:  2017-08-31       Impact factor: 1.351

8.  Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosis.

Authors:  Andrea Angeletti; Chiara Cantarelli; Astgik Petrosyan; Sofia Andrighetto; Kelly Budge; Vivette D D'Agati; Susan Hartzell; Deborah Malvi; Chiara Donadei; Joshua M Thurman; Danica Galešić-Ljubanović; John Cijiang He; Wenzhen Xiao; Kirk N Campbell; Jenny Wong; Clara Fischman; Joaquin Manrique; Gianluigi Zaza; Enrico Fiaccadori; Gaetano La Manna; Miguel Fribourg; Jeremy Leventhal; Stefano Da Sacco; Laura Perin; Peter S Heeger; Paolo Cravedi
Journal:  J Exp Med       Date:  2020-09-07       Impact factor: 17.579

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.